Patents by Inventor Philip Lowry

Philip Lowry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SENSITIVE AND GENERIC ANTIBODIES AND MULTIPLE APPLICATIONS
    Publication number: 20120322089
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • Meprobromate Immunoassay
    Publication number: 20120040378
    Abstract: Carisoprodol is a centrally-acting prescription drug of known abuse. Upon ingestion it is rapidly metabolised to meprobamate, also a prescription drug with abuse potential. Current immunoassays are specific for carisoprodol and therefore have a short window of detection and, furthermore, are ineffective at detecting meprobamate. The current invention, underpinned by an antibody specific for meprobamate, overcomes these deficiencies.
    Type: Application
    Filed: August 9, 2011
    Publication date: February 16, 2012
    Applicant: RANDOX LABORATORIES LIMITED
    Inventors: Elouard Benchikh, Ivan McConnell, Peter Fitzgerald, Philip Lowry
  • Chloral Hydrate Detection
    Publication number: 20120003674
    Abstract: The invention relates to an immunoassay method and kit for the indirect detection of chloral hydrate. The invention is underpinned by a novel immunogen that produces an antibody that is specific for the chloral hydrate metabolite trichloroethanol glucuronide. Detection and quantification of trichloroethanol glucuronide has important applications in clinical toxicology, drug facilitated crime, water testing and solvent exposure.
    Type: Application
    Filed: June 29, 2011
    Publication date: January 5, 2012
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Ivan McConnell, Peter Fitzgerald, Philip Lowry
  • Immunoassay
    Publication number: 20100291600
    Abstract: The present invention provides an immunoassay method for detecting or determining the amount of salvinorin A, salvinorin B and/or analogues thereof in an in vitro sample, an antibody for salvinorin A, salvinorin B and/or analogues thereof and a kit for detecting the presence of or determining the amount of salvinorin A, salvinorin B and its analogues thereof in a sample.
    Type: Application
    Filed: April 27, 2010
    Publication date: November 18, 2010
    Applicant: RANDOX LABORATORIES, LTD.
    Inventors: Stephen P. Fitzgerald, Robert I. McConnell, Philip A. Lowry, Elouard Benchikh
  • Phenethanolamine-derived haptens, immunogens, antibodies and conjugates
    Patent number: 7192722
    Abstract: The present invention relates to a method for preparing haptens of formulae I and II that are useful in the preparation of immunogens, antibodies and conjugates, for use in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine. The haptens are prepared by reacting a phenylethanolamine derivative of formula D with a phenylalkylcarbonyl derivative of formula E: in which, in formula I, Z1 is a crosslinker and Z2 is H and, in formula II, Z1 is H and Z2 is a crosslinker.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: March 20, 2007
    Assignee: Randox Laboratories
    Inventors: Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry
  • Haptens, immunogens and antibodies to oxycodone and its metabolites
    Patent number: 7026134
    Abstract: Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: April 11, 2006
    Assignee: Randox Laboratories Ltd.
    Inventors: John Victor Lamont, Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry
  • Haptens, immunogens and antibodies to oxycodone and its metabolites
    Publication number: 20030157565
    Abstract: Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III 1
    Type: Application
    Filed: December 20, 2002
    Publication date: August 21, 2003
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: John Victor Lamont, Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry